Massif Capital's Q3 2025 Real Assets Strategy returned 36.1% net, YTD 41.5%, with strong Alpha and Sortino. Discusses gold, ...

This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term.

The distribution management playbook is being rewritten in real-time. Across distribution centers and wholesale operations, ...

Turn information overload into actionable insight and gain understanding of the macroeconomic elements driving market actions.

Zoom (ZM) stock stands apart in the AI era. Learn how increased AI use could boost meeting needs and what this means for the ...

With data as of October 27, 2025, we examine if Journey Medical Corporation(DERM) is consistently building momentum based on AAII's A+ Investor Momentum and Value Scores and Grades.

Structural changes in financial markets mean we need a different mix of asset classes to deliver dependable returns ...

Anthropic launches Claude for Excel, bringing powerful AI tools to financial analysts and Wall Street firms as it expands ...

AS WE END THE THIRD QUARTER OF 2025, THE US STOCK MARKET FACES AN UNUSUAL SITUATION. IN THIS LETTER, WE OUTLINE HOW EQUITAS ...

Here's how you can access a raft of upgrades intended to boost the chatbot's financial prowess and access to real-time market ...